The Cognitive Assessment Training Market in Numbers

Nobody agrees on how big this market is, and a founder should say so in the plan rather than quote the flattering figure. Published estimates for 2025 range from roughly $5.9 billion to $9.3 billion, with forecast growth between 16 and 22 percent a year depending on the publisher and on whether cognitive training software, neuropsychology services and clinical trial testing are counted together. You can see the spread yourself in the summaries from Fortune Business Insights and Precedence Research. A lender reading your plan will trust a range with a stated method far more than a single headline number copied from a press release.

Two details inside those reports matter more than the total. First, digital assessment platforms held about 46 percent of the 2025 market, and the hosted segment is growing near 18 percent a year. Second, hospitals are the largest buying group while clinics are the fastest growing. For a training business, that second point is the real signal: hospital systems already have education departments, whereas independent clinics, memory practices and primary care groups have no one to teach their staff how to run a screen and document it properly. That gap is the commercial opening.

Regional splits differ by publisher. One set of figures puts North America near 38 percent of 2025 revenue (Mordor Intelligence), another puts it above 56 percent, and Mordor has Asia Pacific growing fastest at roughly 22 percent a year to 2031. Treat the North American share as somewhere between 38 and 56 percent, and plan on the US and UK as your launch markets because that is where clinician reimbursement and national dementia targets create paid demand.

What the demand figures mean for a training company

The US figure is a prevalence number, not a sales number, but it explains why payers pay. Medicare's Annual Wellness Visit has required detection of cognitive impairment since the Affordable Care Act, yet the statute only asks for assessment by direct observation with input from patients and families. Studies of Medicare data, including work published in Alzheimer's & Dementia, show that structured test use at these visits is uneven and driven by practice habit more than patient risk. Uneven habit is what training sells against. A practice that has never standardised its screen has no internal expert, and the cheapest fix is a half-day course plus a laminated workflow.

In England the situation is similar in a different shape. The diagnosis rate sits around 65 percent, which means roughly one in three people with dementia has no recorded diagnosis, and memory services run waiting lists measured in months. Anything that moves a competent first-line cognitive screen from the specialist clinic into primary care and community teams relieves that queue. Trusts and integrated care boards buy training for that reason, usually from a CPD budget that is small per head but spread over many staff.

The final number to put in your plan is the cost of getting it wrong. Late or missed identification pushes families into crisis care, and that is the story every procurement lead in this sector already tells internally. Your plan does not need to prove the economics of dementia. It needs to show that your course is the lowest-cost, lowest-risk way for a named buyer to act on a problem they already budget for.

Three Ways to Build This Business, Compared

"Cognitive assessment training healthcare" covers three quite different companies. Founders who blur them write plans that no lender can price. Pick one as the primary model, state the second as a phase-two option, and leave the third out unless you have clinical leadership in the founding team.

The training model is the one this template is built around, because it is the only one a non-clinical founder can launch for under $150,000 without a regulatory filing. The platform model is where the money in this sector has actually gone. BrainCheck, for example, reports about $49.8 million raised across 13 rounds, including a $13 million Series A extension announced in February 2026 (BrainCheck announcement). That is a venture-scale path with validation studies and a sales team, and it needs a different plan from the one you will write here.

The delivered-service model deserves a sober paragraph in any plan because it looks easy on a spreadsheet. A single neuropsychological testing evaluation billed under CPT 96132 pays about $125 for the first hour under the 2025 Medicare schedule, and cognitive assessment with care planning under CPT 99483 pays about $266. Those numbers read well until you subtract psychologist time, scoring, report writing and denied claims. Most training founders who add a service arm do it later, with a licensed clinical director already in place.

What It Costs to Launch a Cognitive Assessment Training Company

A training-first launch needs $38,000 to $145,000 in the US or £22,000 to £95,000 in the UK. These are Avvale planning ranges built from the client plans we have written in healthcare education, not published industry statistics, and the spread is wide for a reason: the low end assumes the founder is also the lead instructor and builds the first course alone, while the high end buys outside subject-matter experts and a recorded video library from day one.

Cost breakdown

• Curriculum development: $9,000-$35,000 (£5K-£22K). Subject-matter expert fees, instructional design, case vignettes, scoring exercises and a pre/post knowledge test. Plan 120 to 300 hours for the first two-day course.
• Learning platform, video and assessment tooling: $3,000-$12,000 (£2K-£8K). A hosted LMS such as Thinkific, Moodle Workplace or LearnDash, a webinar tool such as Zoom, and a certificate engine such as Accredible. Plan on two to four months of subscriptions before the first sale.
• Accreditation and CPD applications: $2,000-$9,000 (£1K-£5K). In the US, credit for physicians runs through an ACCME-accredited provider partner or your own accreditation; for nurses and psychologists, state boards and professional associations each have their own approval route. In the UK, CPD accreditation bodies charge per course.
• Professional indemnity and cyber cover: $2,500-$6,500 (£1.5K-£4K) a year. Training that is relied on in patient care needs real indemnity limits, and lenders will ask for a certificate.
• Test and content licensing: $0-$8,000. Teaching the MoCA, for instance, does not require you to resell it, but demonstrating licensed batteries in class means checking each publisher's terms first.
• Launch marketing: $6,000-$25,000 (£3.5K-£15K). Conference exhibit space, two webinar series, a LinkedIn campaign aimed at practice managers and geriatric clinicians, and a referral scheme for existing customers.
• Working capital, four months: $15,000-$55,000 (£9K-£35K). Corporate and health-system customers pay on 45 to 90 day terms, so cash lags revenue even when sales are good.

How a lender will read the budget

The line that draws questions is curriculum. Lenders have seen too many training plans where the product is a slide deck written over a weekend. Show hours, named reviewers and the credential each reviewer holds. A board-certified neuropsychologist or geriatrician on your advisory page, with a stated review fee in the budget, does more for the application than a larger marketing line. The second question is accreditation timing. Do not model a full seat count in month one if your credit approval takes eight weeks.

SBA and Start Up Loan Funding for a Training Business

Training companies sit under NAICS 611430, professional and management development training, when they teach working professionals. The SBA size standard for that code is $15 million in average annual receipts, effective March 2023, so almost every new entrant qualifies as a small business. Lender-facing summaries of this code, such as the NAICS 611430 listing, note that new training centres typically close 7(a) loans between $75,000 and $500,000, with larger amounts reserved for acquisitions or founders with three years of training revenue behind them. The SBA's own 7(a) programme page caps loans at $5 million.

Equity injection is the number to plan first. On a $120,000 loan request, a 10 percent injection is $12,000 of founder cash, and a lender who wants 20 percent will ask for $24,000 on a budget of that size. Founders who are clinicians moving out of salaried posts often underestimate this, because their savings are tied up in a mortgage rather than a bank balance. The plan should show where the injection comes from and keep it separate from borrowed money.

Collateral is the other sticking point. A training company owns little: laptops, camera equipment and content. SBA lenders generally take available business assets and a personal guarantee, and for loans of this size they can look at personal real estate when the loan is not fully secured. If that is a concern, an SBA microloan through a community lender is worth modelling beside a 7(a), usually at a lower amount and with technical assistance attached. Economic development nonprofits in cities with academic medical centres, such as Pittsburgh, Cleveland and the Research Triangle, run these programmes and know the local health systems.

In the UK, the Start Up Loans scheme suits a single-founder clinical training company that needs under £25,000 and can use the mentoring. Larger programmes, such as an Innovate UK grant for a digital tool or a regional growth fund, usually require a technology claim that a pure training business does not make. If you intend to add a software component later, flag it in the plan as a phase-two raise rather than mixing it into the launch ask.

Revenue Model and Per-Seat Unit Economics

A cognitive assessment training company earns from four sources, and the plan should model each separately: live workshops, self-paced courses, enterprise or site licences, and recertification. Recertification is the one founders forget, and it is the one that turns a one-off course into a repeating revenue line. The MoCA programme, as a reference point, charges $150 for initial training and certification and $75 to recertify, and recommends retraining after two years at half the initial price (MoCA Cognition training page). It is free to students, faculty, academic researchers and publicly operated healthcare institutions, which tells you where the price ceiling for the plain "how to administer one test" product sits, and why a commercial trainer has to teach more than one test.

Worked example: one live workshop

A two-day live workshop for 24 clinicians priced at $495 a seat produces $11,880 of revenue. Direct costs are $1,600 for room and audiovisual, $2,500 for a lead instructor if the founder is not teaching, $528 for printed workbooks at $22 a seat, $356 in card processing at three percent, and $1,400 of marketing at about $58 per filled seat. That totals $6,384, leaving a contribution of $5,496, or 46 percent, before overhead. Drop the room to a hospital's donated conference space and the contribution rises to roughly 59 percent; fill only 14 seats and it falls below 20 percent. Fill rate is the variable that decides whether live teaching pays.

Year-one revenue build

• Live workshops: 18 sessions at an average of 20 seats and $495 yields $178,200.
• Self-paced library: 600 seats at $149 yields $89,400, with a gross margin above 80 percent once the content is built and card fees are covered.
• Enterprise site licences: 6 health systems or large groups at $14,000 for unlimited staff access for a year yields $84,000.
• Total: $351,600, of which live teaching is 51 percent. By year three, a healthy mix flips toward licences and recertification, which carry less delivery cost.

That build is a composite for illustration, not a forecast for your market. Replace the seat counts with your own pipeline and cite where each number comes from. A lender will accept 18 workshops a year more readily if five of them are already booked with named hospital education departments.

Reimbursement as a selling tool, not a revenue line

A training company does not bill Medicare, but the schedule drives your customer's willingness to pay. CPT 99483, cognitive assessment and care planning, pays about $266.21 under the 2025 national Medicare rate (Creyos billing guide, with CMS description in the MLN fact sheet). CPT 96132 pays about $125.18 for the first hour in 2025 and $122.25 in 2026, while CPT 96127, brief standardised screening, pays only $4.53 in 2025 and $5.01 in 2026, with a three-unit visit limit (Therathink rate summary). A practice that completes one 99483 visit a week recovers a $2,000 course fee in under eight weeks from that code alone. Put that arithmetic in your sales deck and in the plan.

Rates are national figures before geographic adjustment, and they change each January. Your plan should say so and should not promise customers a specific payout. What you can promise is documentation: a clinician trained in the 99483 elements (informant interview, functional assessment, safety evaluation, care plan, caregiver education) is far less likely to have a claim denied for missing components.

Who You Will Be Compared With

No buyer evaluates you in a vacuum. They compare you with the vendors and publishers they already know, and your plan should name them and say where you fit. The table above splits the models; here is what the public record shows for the main names.

• Cogstate: an Australian-listed cognitive testing company whose revenue reached $53.09 million in fiscal 2025, up 22 percent, with profit before tax of $13.9 million, most of it from clinical trial testing (StockAnalysis). Its COGNIGRAM system was reviewed under 510(k) K171658 as a Class II exempt device. Lesson for you: the profitable end of this sector is pharma, not clinics.
• Cambridge Cognition: UK AIM-listed, revenue of £9.4 million in 2025 against £10.3 million in 2024, across 114 clinical studies and 340 academic programmes (2025 annual report). Its CANTAB Paired Associates Learning tool holds 510(k) K161328. Lesson: even the best-known UK name is small, so demand is real but not enormous.
• BrainCheck: a US platform aimed at primary care and neurology groups, with the funding history described above. It competes for the same practice-manager budget as a training company and sometimes bundles onboarding.
• Cognetivity Neurosciences: maker of the five-minute iPad-based Integrated Cognitive Assessment, deployed at North Staffordshire Combined Healthcare NHS Trust in a dementia care pathway (company release). A good example of an NHS pilot that a training partner could support.
• Linus Health and Cognivue: Linus Health's Digital Clock and Recall is listed as a Class II, 510(k)-exempt Computerized Cognitive Assessment Aid under product code PTY. Cognivue received a De Novo authorisation in 2015 (DEN130033), which created the 21 CFR 882.1470 classification the rest of the field now uses.

Most of these companies train customers on their own product. That is useful positioning: you are the vendor-neutral option that teaches the underlying skill, from interview technique to score interpretation, and can work with whichever tool the practice buys. Say that in the plan and name two tool vendors you intend to partner with.

Regulation, Accreditation and Test Licensing

A training company is not a device maker or a care provider, but the line between them is thinner here than in most education businesses. The plan needs a short compliance section that shows you know where it is.

United States

• FDA device classification: Software that aids cognitive assessment falls under 21 CFR 882.1470, Computerized Cognitive Assessment Aid, Class II. Many products are 510(k)-exempt after the original De Novo; Cognivue (DEN130033) created the category. A training company that only teaches is outside this rule. A company that sells its own scoring software is inside it. Keep your marketing claims on the education side.
• CME and CE credit: Physician credit normally comes through an ACCME-accredited provider. Nurse, psychologist, social worker and OT credit varies by state board. Budget for the approval fee and the lead time.
• Test-publisher terms: Neuropsychological batteries are sold by qualification level, and some publishers restrict who may purchase or be trained on them. The MoCA programme requires certification for anyone interpreting individual tasks or sub-scores, though certification is optional for clinicians who use only the total score for screening, triage or referral (MoCA certification terms).
• HIPAA: If learners upload real patient cases or you run live assessments with patients present, you become a business associate. Use de-identified or synthetic vignettes in the course and write that rule into your instructor guide.
• State licensure: Teaching a test is not practising psychology, but providing assessments under contract is. If you add a service arm, check each state's psychology and telehealth rules.

United Kingdom

• CQC registration: Providing dementia or cognitive assessments to patients is a regulated activity needing registration with the Care Quality Commission (NHS AI and Digital Regulations Service). Pure training does not require it.
• MHRA and UKCA: Standalone software that meets the medical device definition must be UKCA marked under the Medical Devices Regulations 2002, as amended; see MHRA digital mental health technology guidance.
• HCPC and CPD: Practitioner psychologists are regulated by the HCPC, which requires continuing professional development from all registrants. That requirement is your marketing hook with psychologists, occupational therapists and speech and language therapists.
• Data protection: UK GDPR applies to learner records, and the NHS Data Security and Protection Toolkit is usually requested by trust buyers.

European Union

• MDR Rule 11: Software that informs diagnostic decisions is often Class IIa or above and needs a notified body. Published budgets for Class IIa certification run about EUR 32,000 to EUR 110,000 over 9 to 18 months, with new certifications quoted at EUR 50,000 to EUR 80,000 or more as of late 2025 (MedDeviceGuide cost breakdown). Again, this applies to you only if you build software.
• National education rules: Recognition of CPD credits is national, not European. Plan one country at a time.

Who Buys, and How Long They Take

Four buyer types account for nearly all revenue in this niche, and each has a different sales cycle. A plan that treats them as one "healthcare customer" will overstate early cash.

Individual clinicians

A psychologist, nurse practitioner or occupational therapist buys on a card, usually after a colleague recommendation or a conference talk. The cycle is days, the ticket is $149 to $495, and the buyer cares about credit hours and a certificate. This channel fills webinars and early cohorts, but it carries the highest marketing cost per dollar of revenue.

Independent practices and clinic groups

The decision-maker is a practice manager or medical director. Cycles run two to six weeks and tickets run $1,500 to $6,000 for a staff session. The pitch that works is operational: standardise the screen, document it so the claim survives audit, and cut the minutes spent per visit. Offer an on-site or live-virtual option and a one-page workflow the practice can laminate.

Health systems and trusts

Education departments, quality leads and service line directors run procurement through committees. Expect three to nine months from first call to purchase order, a pilot before any site licence, and a request for outcome data. In England, integrated care boards and mental health trusts follow the same pattern with tenders and frameworks. A signed pilot with 100 to 150 clinicians is a more convincing plan asset than a long list of interested contacts.

Universities and professional bodies

Nursing, psychology and medical programmes buy or co-develop modules. Margins are lower, but one adoption puts your content in front of several hundred graduating clinicians a year and creates a pipeline into paid CPD later. Note that publicly operated institutions often receive test-publisher training for free, so your value has to be the clinical workflow, not the instrument basics.

Launch timeline

• Months 1-2: Form the entity, recruit two clinical reviewers, confirm test-publisher terms and request accreditation applications.
• Months 2-4: Build the first workshop and the first two online modules, then run a free beta with 10 to 15 clinicians to collect the pre/post scores.
• Months 4-6: Open paid enrolment, run the first live cohort, and begin a pilot conversation with one health system.
• Months 6-12: Add the remaining modules, publish outcomes data, move the pilot customer to a site licence, and hire or train a second instructor.

The timeline is deliberately slow on accreditation and fast on beta testing. Credit approval is the part you cannot rush, so the beta cohort is how you keep building proof while you wait. In our experience a plan that shows a free beta with measured results in month three raises fewer lender objections than one that jumps straight to a paid launch.

Mistakes That Sink New Entrants

These come from patterns in the healthcare education plans we review, not from any single client.

• Making device claims in a course brochure. Saying that your programme "detects dementia" turns a training product into a diagnostic claim. Say that it teaches clinicians to administer, score and document recognised screens.
• Launching without credit. A clinician choosing between two courses will pick the one that counts toward licence renewal. If your accreditation arrives after launch, your first cohort will be half empty.
• Teaching one test. A single-instrument course competes with a free or $150 first-party option. Teach the pathway: when to screen, which instrument for which patient, how to talk to families, what to document, and when to refer.
• Pricing only per head. A $149 individual seat does not cover a sales call to a hospital. Build a site-licence tier from day one and price it against the cost of the education manager's time.
• Skipping outcomes data. A pre/post knowledge test and a 90-day follow-up survey on screening rates cost almost nothing to run and become the proof that wins the second contract.
• Hiring one famous instructor. If revenue depends on one person's calendar, a lender sees a key-person risk. Train a second instructor in year one.

Terms You Will Meet

• Computerized Cognitive Assessment Aid: the FDA's name for software that helps clinicians measure cognitive function, defined under 21 CFR 882.1470.
• 510(k)-exempt: a device type the FDA has exempted from premarket notification once its classification is established.
• SaMD: software as a medical device, regulated by function rather than by the hardware it runs on.
• CPT 99483: the billing code for cognitive assessment and care planning for a patient with cognitive impairment.
• Annual Wellness Visit: the Medicare visit that must include detection of cognitive impairment.
• Informant interview: a structured conversation with a family member or carer, a required part of a full cognitive care-planning visit.
• CPD: continuing professional development, the UK term for ongoing training that regulators require.
• Equity injection: the cash a borrower puts into a startup before an SBA lender advances funds.

Sample Business Plan Extract

This extract shows how our plans handle the opening section for a company of this type, so you can see the level of specificity you will receive:

What Is in the Template

Every Avvale business plan template includes these sections, pre-structured for your industry. For a cognitive assessment training company we add prompts for accreditation status, clinical advisory board, test-publisher licensing and outcomes measurement.

• Executive Summary - Your company at a glance, written to be understood by a loan officer in a minute
• Company Overview - Legal structure, ownership, clinical leadership and credentials
• Industry Analysis - Market size range, reimbursement drivers and dementia prevalence
• Customer Analysis - Practices, health systems, universities and care-home groups, with buying cycles
• Competitor Analysis - Platform vendors, publishers and other trainers, mapped against your offer
• Marketing Plan - Conference, webinar, referral and partnership channels. See also our marketing plan for cognitive assessment training healthcare businesses
• Operations Plan - Curriculum build, instructor roster, delivery calendar and quality assurance
• Management Team - Founder bios, clinical advisors and planned hires

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis and startup capital requirements. If your concept overlaps with clinical practice, see our neurology practice business plan template; for a broader training concept, the training center business plan template may fit better. Our business plan writer page explains how we work with healthcare founders.

Questions Buyers Ask